研飞ivySCI (青藤学术）

Cancer Gene Therapy

短名	Cancer Gene Ther
Journal Impact	4.67
国际分区	ONCOLOGY(Q1)
期刊索引	SCI Q1中科院 3 区

ISSN	0929-1903, 1476-5500
h-index	99
国内分区	医学(3区)医学生物工程与应用微生物(2区)医学遗传学(3区)医学医学研究与实验(3区)医学肿瘤学(4区)

癌症基因治疗是癌症研究人员和临床医生必不可少的基因和细胞治疗资源，让读者了解癌症基因和细胞治疗的最新进展。该杂志发表原创的实验室和临床研究论文、病例报告和评论文章。出版主题包括 RNAI 方法、耐药性、造血祖细胞基因转移、癌症干细胞、细胞疗法、同源重组、核酶技术、反义技术、肿瘤免疫治疗和肿瘤抑制、转化研究、癌症治疗、基因传递系统（病毒和非-病毒）、抗基因治疗（反义、SIRNA和核酶）、细胞凋亡；机制和疗法、疫苗开发、免疫学和免疫疗法、DNA 合成和修复。CANCER GENE THERAPY 发表应用于癌症研究的基因转移/基因疗法和细胞疗法领域的实验室调查、临床前研究和临床试验的结果。发表的文章类型包括原创研究文章；病例报告；简短的交流；耐药/敏感性、基因治疗、细胞治疗、抑癌与抗癌基因治疗、细胞因子/肿瘤免疫治疗等主要领域的综述文章；行业观点；和给编辑的信。

期刊主页投稿网址

涉及主题	生物遗传学医学化学生物化学癌症研究基因内科学癌症免疫学细胞培养分子生物学遗传增强体外免疫系统病毒学细胞凋亡细胞生物学病理病毒转染重组DNA生物技术体内
出版信息	出版商: Springer Nature，出版周期: Monthly，期刊类型: journal
基本数据	创刊年份: 1994，原创研究文献占比: 85.52%，自引率:2.10%， Gold OA占比: 37.11%
平均审稿周期	网友分享经验：偏慢,4-8周
平均录用比例	网友分享经验：较易

期刊引文格式

这些示例是对学术期刊文章的引用，以及它们应该如何出现在您的参考文献中。

并非所有期刊都按卷和期组织其已发表的文章，因此这些字段是可选的。有些电子期刊不提供页面范围，而是列出文章标识符。在这种情况下，使用文章标识符而不是页面范围是安全的。

只有1位作者的期刊

有2位作者的期刊

有3位作者的期刊

有5位以上作者的期刊

书籍引用格式

以下是创作和编辑的书籍的参考文献的示例。

学位论文引用格式

网页引用格式

这些示例是对网页的引用，以及它们应该如何出现在您的参考文献中。

专利引用格式

HN1-mediated activation of lipogenesis through Akt-SREBP signaling promotes hepatocellular carcinoma cell proliferation and metastasis

2024-9-9

Caveolin-1 knockout mitigates breast cancer metastasis to the lungs via integrin α3 dysregulation in 4T1-induced syngeneic breast cancer model

2024-9-7

The Exon Junction Complex component EIF4A3 plays a splicing-linked oncogenic role in pancreatic ductal adenocarcinoma

2024-9-4

NF-κB-activated oncogene inhibition strategy for cancer gene therapy

2024-9-3

ZNF460-mediated upregulation of APCDD1L-DT promotes cholangiocarcinoma development by inhibiting the ubiquitin-mediated degradation of DVL2

2024-8-30

FGFR4-specific CAR-T cells with inducible caspase-9 suicide gene as an approach to treat rhabdomyosarcoma

2024-8-25

Identification of KIFC1 as a putative vulnerability in lung cancers with centrosome amplification

2024-8-24

Mesothelin expression correlates with elevated inhibitory immune activity in patients with colorectal cancer

2024-8-22

Long noncoding RNA EPCART regulates translation through PI3K/AKT/mTOR pathway and PDCD4 in prostate cancer

2024-8-15

PHF10 inhibits gastric epithelium differentiation and induces gastric cancer carcinogenesis

2024-8-10

The splicing factor SF3B1 confers ferroptosis resistance and promotes lung adenocarcinoma progression via upregulation of SLC7A11

2024-8-10

UGT1A7 altered HER2-positive breast cancer response to trastuzumab by affecting epithelial-to-mesenchymal transition: A potential biomarker to identify patients resistant to trastuzumab treatment

2024-8-10

Arsenic trioxide and p97 inhibitor synergize against acute myeloid leukemia by targeting nascent polypeptides and activating the ZAKα–JNK pathway

2024-8-9

Polθ: emerging synthetic lethal partner in homologous recombination-deficient tumors

2024-8-9

Switching anti-EGFR antibody re-sensitizes head and neck cancer patient following acquired resistance to cetuximab

2024-7-31

Rabenosyn-5 suppresses non-small cell lung cancer metastasis via inhibiting CDC42 activity

2024-7-29

ZDHHC1 downregulates LIPG and inhibits colorectal cancer growth via IGF2BP1 Palmitoylation

2024-7-28

The long-term effectiveness and mechanism of oncolytic virotherapy combined with anti-PD-L1 antibody in colorectal cancer patient

2024-7-27

Pathophysiological role of ion channels and transporters in hepatocellular carcinoma

2024-7-24

Atypical phosphatase DUSP11 inhibition promotes nc886 expression and potentiates gemcitabine-mediated cell death through NF-kB modulation

2024-7-24

Therapeutic activity of retroviral replicating vector-mediated gene therapy in combination with anti-PD-1 antibody in a murine pancreatic cancer model

2024-7-23

Atypical cellular responses mediated by intracellular constitutive active TrkB (NTRK2) kinase domains and a solely intracellular NTRK2-fusion oncogene

2024-7-22

HADHA promotes glioma progression by accelerating MDM2-mediated p53 ubiquitination

2024-7-22

NF-κB role on tumor proliferation, migration, invasion and immune escape

2024-7-20

CCT6A promotes cell proliferation in colon cancer by targeting BIRC5 associated with p53 status

2024-7-13

Long-term severe hypoxia adaptation induces non-canonical EMT and a novel Wilms Tumor 1 (WT1) isoform

2024-7-8

Correction: H3.3-G34W in giant cell tumor of bone functionally aligns with the exon choice repressor hnRNPA1L2

2024-6-27

Anti-angiogenesis and anti-immunosuppression gene therapy through targeting COUP-TFII in an in situ glioblastoma mouse model

2024-6-26

Correction: TRIM58 downregulation maintains stemness via MYH9-GRK3-YAP axis activation in triple-negative breast cancer stem cells

2024-6-25

Extracellular vesicles from type-2 macrophages increase the survival of chronic lymphocytic leukemia cells ex vivo

2024-6-25

Gut microbiota-mediated activation of GSDMD ignites colorectal tumorigenesis

2024-6-19

Deciphering the role of post-translational modifications in fanconi anemia proteins and their influence on tumorigenesis

2024-6-15

ScRNA-seq revealed the tumor microenvironment heterogeneity related to the occurrence and metastasis in upper urinary tract urothelial carcinoma

2024-6-14

Lower ratio of IMPDH1 to IMPDH2 sensitizes gliomas to chemotherapy

2024-6-13

RhoJ: an emerging biomarker and target in cancer research and treatment

2024-6-10

Human adipose-derived stem cells genetically programmed to induce necroptosis for cancer immunotherapy

2024-6-10

Proteomic profiling reveals ACSS2 facilitating metabolic support in acute myeloid leukemia

2024-6-8

Regulatory roles of N6-methyladenosine (m6A) methylation in RNA processing and non-communicable diseases

2024-6-5

Integrating system biology and intratumor gene therapy by trans-complementing the appropriate co-stimulatory molecule as payload in oncolytic herpes virus

2024-6-5

Retraction Note: miR-182 regulates trastuzumab resistance by targeting MET in breast cancer cells

2024-6-5

Manipulating the tumour immune microenvironment by N6-methyladenosine RNA modification

2024-6-4

H3.3-G34W in giant cell tumor of bone functionally aligns with the exon choice repressor hnRNPA1L2

2024-5-29

Unveiling mitochondrial and ribosomal gene deregulation and tumor microenvironment dynamics in acute myeloid leukemia

2024-5-28

Hsa_circ_0007590/PTBP1 complex reprograms glucose metabolism by reducing the stability of m6A-modified PTEN mRNA in pancreatic ductal adenocarcinoma

2024-5-27

CircPKN2 promotes ferroptosis in bladder cancer by promoting the ubiquitination of Stearoyl-CoA Desaturase 1

2024-5-27

IGF2BP2-modified circular RNA circCHD7 promotes endometrial cancer progression via stabilizing PDGFRB and activating JAK/STAT signaling pathway

2024-5-22

Phosphoglycerate mutase 1 promotes breast cancer progression through inducing immunosuppressive M2 macrophages

2024-5-15

Dickkopf-1 (DKK1) drives growth and metastases in castration-resistant prostate cancer

2024-5-13

Targeting KRASG12D mutation in non-small cell lung cancer: molecular mechanisms and therapeutic potential

2024-5-11

TRIM58 downregulation maintains stemness via MYH9-GRK3-YAP axis activation in triple-negative breast cancer stem cells

2024-5-7

帮你贴心管理全部的文献
研飞ivySCI，高效的论文管理

投稿经验分享

分享我的经验，帮你走得更远

Cancer Gene Therapy

期刊引文格式

只有1位作者的期刊

有2位作者的期刊

有3位作者的期刊

有5位以上作者的期刊

书籍引用格式

学位论文引用格式

网页引用格式

专利引用格式

最新文章

HN1-mediated activation of lipogenesis through Akt-SREBP signaling promotes hepatocellular carcinoma cell proliferation and metastasis

Caveolin-1 knockout mitigates breast cancer metastasis to the lungs via integrin α3 dysregulation in 4T1-induced syngeneic breast cancer model

The Exon Junction Complex component EIF4A3 plays a splicing-linked oncogenic role in pancreatic ductal adenocarcinoma

NF-κB-activated oncogene inhibition strategy for cancer gene therapy

ZNF460-mediated upregulation of APCDD1L-DT promotes cholangiocarcinoma development by inhibiting the ubiquitin-mediated degradation of DVL2

FGFR4-specific CAR-T cells with inducible caspase-9 suicide gene as an approach to treat rhabdomyosarcoma

Identification of KIFC1 as a putative vulnerability in lung cancers with centrosome amplification

Mesothelin expression correlates with elevated inhibitory immune activity in patients with colorectal cancer

Long noncoding RNA EPCART regulates translation through PI3K/AKT/mTOR pathway and PDCD4 in prostate cancer

PHF10 inhibits gastric epithelium differentiation and induces gastric cancer carcinogenesis

The splicing factor SF3B1 confers ferroptosis resistance and promotes lung adenocarcinoma progression via upregulation of SLC7A11

UGT1A7 altered HER2-positive breast cancer response to trastuzumab by affecting epithelial-to-mesenchymal transition: A potential biomarker to identify patients resistant to trastuzumab treatment

Arsenic trioxide and p97 inhibitor synergize against acute myeloid leukemia by targeting nascent polypeptides and activating the ZAKα–JNK pathway

Polθ: emerging synthetic lethal partner in homologous recombination-deficient tumors

Switching anti-EGFR antibody re-sensitizes head and neck cancer patient following acquired resistance to cetuximab

Rabenosyn-5 suppresses non-small cell lung cancer metastasis via inhibiting CDC42 activity

ZDHHC1 downregulates LIPG and inhibits colorectal cancer growth via IGF2BP1 Palmitoylation

The long-term effectiveness and mechanism of oncolytic virotherapy combined with anti-PD-L1 antibody in colorectal cancer patient

Pathophysiological role of ion channels and transporters in hepatocellular carcinoma

Atypical phosphatase DUSP11 inhibition promotes nc886 expression and potentiates gemcitabine-mediated cell death through NF-kB modulation

Therapeutic activity of retroviral replicating vector-mediated gene therapy in combination with anti-PD-1 antibody in a murine pancreatic cancer model

Atypical cellular responses mediated by intracellular constitutive active TrkB (NTRK2) kinase domains and a solely intracellular NTRK2-fusion oncogene

HADHA promotes glioma progression by accelerating MDM2-mediated p53 ubiquitination

NF-κB role on tumor proliferation, migration, invasion and immune escape

CCT6A promotes cell proliferation in colon cancer by targeting BIRC5 associated with p53 status

Long-term severe hypoxia adaptation induces non-canonical EMT and a novel Wilms Tumor 1 (WT1) isoform

Correction: H3.3-G34W in giant cell tumor of bone functionally aligns with the exon choice repressor hnRNPA1L2

Anti-angiogenesis and anti-immunosuppression gene therapy through targeting COUP-TFII in an in situ glioblastoma mouse model

Correction: TRIM58 downregulation maintains stemness via MYH9-GRK3-YAP axis activation in triple-negative breast cancer stem cells

Extracellular vesicles from type-2 macrophages increase the survival of chronic lymphocytic leukemia cells ex vivo

Gut microbiota-mediated activation of GSDMD ignites colorectal tumorigenesis

Deciphering the role of post-translational modifications in fanconi anemia proteins and their influence on tumorigenesis

ScRNA-seq revealed the tumor microenvironment heterogeneity related to the occurrence and metastasis in upper urinary tract urothelial carcinoma

Lower ratio of IMPDH1 to IMPDH2 sensitizes gliomas to chemotherapy

RhoJ: an emerging biomarker and target in cancer research and treatment

Human adipose-derived stem cells genetically programmed to induce necroptosis for cancer immunotherapy

Proteomic profiling reveals ACSS2 facilitating metabolic support in acute myeloid leukemia

Regulatory roles of N6-methyladenosine (m6A) methylation in RNA processing and non-communicable diseases

Integrating system biology and intratumor gene therapy by trans-complementing the appropriate co-stimulatory molecule as payload in oncolytic herpes virus

Retraction Note: miR-182 regulates trastuzumab resistance by targeting MET in breast cancer cells

Manipulating the tumour immune microenvironment by N6-methyladenosine RNA modification

H3.3-G34W in giant cell tumor of bone functionally aligns with the exon choice repressor hnRNPA1L2

Unveiling mitochondrial and ribosomal gene deregulation and tumor microenvironment dynamics in acute myeloid leukemia

Hsa_circ_0007590/PTBP1 complex reprograms glucose metabolism by reducing the stability of m6A-modified PTEN mRNA in pancreatic ductal adenocarcinoma

CircPKN2 promotes ferroptosis in bladder cancer by promoting the ubiquitination of Stearoyl-CoA Desaturase 1

IGF2BP2-modified circular RNA circCHD7 promotes endometrial cancer progression via stabilizing PDGFRB and activating JAK/STAT signaling pathway

Phosphoglycerate mutase 1 promotes breast cancer progression through inducing immunosuppressive M2 macrophages

Dickkopf-1 (DKK1) drives growth and metastases in castration-resistant prostate cancer

Targeting KRASG12D mutation in non-small cell lung cancer: molecular mechanisms and therapeutic potential

TRIM58 downregulation maintains stemness via MYH9-GRK3-YAP axis activation in triple-negative breast cancer stem cells

帮你贴心管理全部的文献.css-5myebc{font-size:14px;font-weight:var(--chakra-fontWeights-normal);margin-top:var(--chakra-space-1);margin-bottom:var(--chakra-space-1);}研飞ivySCI，高效的论文管理

帮你贴心管理全部的文献
研飞ivySCI，高效的论文管理